```html

Urachal Anomaly – Comprehensive Medical Guide

Overview

A urachal anomaly is a congenital defect of the urachus, a thin tube that connects the fetal bladder to the umbilical cord. After birth the urachus normally closes and becomes a fibrous cord (the median umbilical ligament). When this closure is incomplete, a spectrum of abnormalities can persist, ranging from a simple cyst to a patent (open) channel that can communicate with the bladder or the outside world.

Who it affects: The condition is present from birth, but symptoms usually appear in childhood or early adulthood. Both males and females can be affected, though some series report a slight male predominance (approximately 55‑60%).

Prevalence: Urachal anomalies are rare, estimated at 1 in 5,000–10,000 live births (0.01‑0.02%). Most remain undiagnosed unless they cause symptoms or are incidentally found on imaging.

Symptoms

The clinical presentation varies with the type of anomaly (cyst, sinus, diverticulum, or patent urachus) and whether infection or malignancy has developed. Below is a comprehensive list of possible symptoms, grouped by category.

General / Non‑specific

• Abdominal pain or discomfort – usually localized to the lower abdomen or suprapubic region.
• Palpable midline mass – may be soft or firm, often noticed near the umbilicus.
• Fever or chills – suggestive of infection of the urachal remnant.
• Urinary symptoms – frequency, urgency, dysuria, or hematuria when the anomaly communicates with the bladder.

Umbilical‑related findings

• Clear, yellow, or mucoid discharge from the umbilicus – typical of a urachal sinus or patent urachus.
• Foul‑smelling or purulent discharge – indicates secondary infection.
• Umbilical swelling or redness – may mimic an umbilical hernia or cellulitis.

Infection‑specific signs

• Localized tenderness over the mass
• Warmth and erythema of the overlying skin
• Systemic signs: elevated heart rate, malaise, night sweats

Rare or advanced presentations

• Gross hematuria – possible if the lesion erodes into the bladder.
• Urinary leakage through the umbilicus – classic for a completely patent urachus.
• Abdominal distension or bowel obstruction – very uncommon, may result from a large cyst compressing adjacent structures.
• Palpable abdominal mass in adults – raises concern for urachal carcinoma, a rare but serious complication.

Causes and Risk Factors

The urachus forms between the fourth and seventh weeks of gestation. Failure of complete obliteration can produce any of the following:

• Patent urachus – entire channel remains open.
• Urachal cyst – only the central portion stays patent.
• Urachal sinus – the umbilical end remains open.
• Urachal diverticulum – the bladder end stays open.

Risk factors for developing an anomaly

• Premature birth – the urachus may close later than in full‑term infants.
• Associated congenital anomalies (e.g., omphalocele, bladder exstrophy) – suggest a broader embryologic disturbance.
• Family history – rare reports suggest a possible hereditary component, but data are limited.

Risk factors for complications

• Male sex – slightly higher incidence of infection and malignancy.
• Age > 40 years – risk of urachal carcinoma rises markedly after the fifth decade.
• Chronic irritation or recurrent infections – promote malignant transformation (estimated 0.01–0.18% of urachal remnants become cancerous).

Diagnosis

Diagnosis begins with a thorough history and physical exam, followed by targeted imaging and, when needed, laboratory studies.

Physical examination

• Inspection of the umbilicus for discharge, erythema, or a visible tract.
• Palpation of a midline suprapubic mass; tenderness may point toward infection.

Imaging studies

• Ultrasound – first‑line, non‑invasive; shows cystic or tubular fluid collection, assesses size and relationship to the bladder.
• Computed Tomography (CT) scan – provides detailed anatomy, detects calcifications, and evaluates for malignancy. Contrast‑enhanced CT is preferred when infection or cancer is suspected.
• MRI – excellent soft‑tissue contrast; useful in children to avoid radiation and in cases where CT is equivocal.
• Fistulography – injection of contrast into the umbilical opening to map a patent tract.

Laboratory tests

• Complete blood count (CBC) – may reveal leukocytosis in infection.
• Urinalysis – looks for hematuria, pyuria, or bacteria if urinary communication is suspected.
• Urine culture – guides antibiotic therapy when infection is present.
• Biopsy or cytology – reserved for suspicious masses; required to confirm urachal carcinoma.

Diagnostic criteria (simplified)

1. Midline suprapubic or umbilical mass/discharge.
2. Imaging demonstrating a fluid‑filled tract or cyst arising from the bladder dome.
3. Exclusion of other causes (e.g., omphalitis, ventral hernia).

Treatment Options

Management depends on the type of anomaly, presence of symptoms, and patient age. The goals are to eliminate infection, prevent recurrence, and remove any malignant potential.

Asymptomatic, uncomplicated anomalies

• Observation – small, non‑communicating cysts without infection may be monitored with periodic ultrasound (every 6‑12 months).

Symptomatic or infected anomalies

• Antibiotic therapy – broad‑spectrum oral antibiotics (e.g., amoxicillin‑clavulanate or ciprofloxacin) for 7‑14 days, tailored to culture results.
• Drainage – percutaneous or surgical drainage for large abscesses before definitive surgery.
• Surgical excision – definitive treatment. Options include:
  • Open excision – full removal of the urachal remnant with a cuff of bladder dome; gold standard for large cysts or suspected cancer.
  • Laparoscopic or robotic‑assisted excision – minimally invasive, shorter hospital stay, comparable oncologic outcomes.

Urachal carcinoma

Although rare, when malignancy is diagnosed the treatment follows oncologic principles:

• Surgical resection (partial or radical cystectomy with en bloc urachal excision).
• Adjuvant chemotherapy (e.g., 5‑fluorouracil/cisplatin) for advanced disease.
• Radiation therapy – limited role, considered for local control when surgery is not feasible.

Post‑operative care

• Catheter drainage for 3‑5 days to protect the bladder repair.
• Analgesia, usually non‑opioid NSAIDs unless contraindicated.
• Antibiotic prophylaxis for 24‑48 hours post‑op.
• Follow‑up imaging at 3‑6 months to confirm complete removal.

Living with Urachal Anomaly

Even after successful treatment, patients may worry about recurrence or complications. Here are practical tips for daily life:

• Stay hydrated – adequate fluid intake promotes regular urine flow, which can reduce irritation of any remaining bladder tissue.
• Monitor for new symptoms – any new umbilical discharge, abdominal pain, or changes in urination should prompt medical evaluation.
• Maintain good umbilical hygiene – gentle cleaning with mild soap and thorough drying helps prevent infection.
• Avoid heavy lifting for at least 4‑6 weeks post‑surgery to allow the surgical site to heal.
• Regular follow‑up – yearly abdominal ultrasound is reasonable for patients with a prior urachal cyst, especially if the lesion was not completely removed.
• Physical activity – normal exercise is encouraged once cleared by the surgeon; low‑impact activities (walking, swimming) are ideal during recovery.
• Educate your primary care provider – ensure they are aware of the past urachal anomaly so that any future abdominal imaging is interpreted correctly.

Prevention

Because urachal anomalies originate in fetal development, primary prevention is limited. However, certain measures can reduce the risk of complications:

• Prompt treatment of umbilical infections in newborns and infants.
• Early evaluation of any persistent umbilical discharge or swelling.
• Vaccination against common pathogens (e.g., influenza, pneumococcus) to lower the chance of secondary infection.
• Routine prenatal care – while it does not prevent the anomaly, it facilitates early post‑natal assessment.

Complications

If left untreated, urachal anomalies can lead to several serious problems:

• Recurrent infection – can progress to abscess formation, sepsis, or peritonitis.
• Fistula formation – a persistent connection between bladder and skin can cause continuous urinary leakage.
• Urachal carcinoma – adenocarcinoma is the most common histology; overall prognosis is poor if diagnosed late (5‑year survival 30‑45%).
• Obstruction of urinary flow – large cysts can compress the bladder neck leading to retention.

When to Seek Emergency Care

References

• Mayo Clinic. “Urachal anomalies.” Accessed May 2026. https://www.mayoclinic.org
• National Institutes of Health, National Cancer Institute. “Urachal Cancer Treatment (PDQ®)”. 2024. https://www.cancer.gov
• World Health Organization. “Congenital malformations data”. 2023. https://www.who.int
• Cleveland Clinic. “Urachal cysts and infections”. 2022. https://my.clevelandclinic.org
• Kim, J. et al. “Urachal anomalies in children: a 15‑year institutional review.” *Journal of Pediatric Surgery*, 2021;56(4):720‑727.
• Huang, R. & Lee, Y. “Robotic excision of urachal remnants – outcomes and technique.” *Surgical Endoscopy*, 2023;37:1125‑1133.

```